Status in Israel
Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Tablets 1 x 150 mg |
|
Related information
Dosage
Please refer to the license holder for further details.
Indications
This medicine is intended for the treatment and prevention of osteoporosis in postmenopausal women.
Contra-Indications
* Hypersensitivity to the active substance or to any of the excipients
* Esophagus problems
* Unable to remain in an upright position (sitting or standing) for at least 30
minutes after taking the medicine.
* Hypocalcemia
Special Precautions
Please refer to the license holder for further details.
Side Effects
Please refer to the license holder for further details.
Drug interactions
Please refer to the license holder for further details.
Pregnancy and Lactation
Please refer to the license holder for further details.
Overdose
Please refer to the license holder for further details.
Manufacturer
PHARMSCIENCE INC., CANADA
Licence holder
